Showing results (41-50 of 70) with videos related to

Sort By:
Pageof 7
Iranian Journal of Psychiatry|June 13, 2018
Acetaminophen as Adjuvant to Risperidone in Chronic Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Clinical TrialSomaye Arabzadeh, Atefeh Zeinoddini, Seyed-Ali Mostafavi, et al.
Neuropsychiatric Disease and Treatment|October 3, 2012
Oxybutynin reduces sweating in depressed patients treated with sertraline: a double-blind, placebo-controlled, clinical studyAli Ghaleiha, Leila Jahangard, Zahra Sherafat, et al.
Neuropsychobiology|August 30, 2014
Oral loading of sodium valproate compared to intravenous loading and oral maintenance in acutely manic bipolar patientsAli Ghaleiha, Mohammad Haghighi, Mehdi Sharifmehr, et al.
The International Journal of Neuropsychopharmacology|September 25, 2012
Memantine as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind, placebo-controlled trialAli Ghaleiha, Mahtab Asadabadi, Mohammad-Reza Mohammadi, et al.
Human Psychopharmacology|March 18, 2011
Correlation of adenosinergic activity with superior efficacy of clozapine for treatment of chronic schizophrenia: a double blind randomised trialAli Ghaleiha, Navid Honarbakhsh, Mohammad-Ali Boroumand, et al.
Psychiatry and Clinical Neurosciences|April 24, 2016
Riluzole in augmentation of fluvoxamine for moderate to severe obsessive-compulsive disorder: Randomized, double-blind, placebo-controlled studySahra Emamzadehfard, Atefeh Kamaloo, Koosha Paydary, et al.
Asian Journal of Psychiatry|January 21, 2023
Gender and age differences in suicide attempt: A large population study in the West of IranSaeid Yazdi-Ravandi, Salman Khazaei, Hasan Davari, et al.
Acta Medica Iranica|October 18, 2014
Bupropion in adults with Attention-Deficit/Hyperactivity Disorder: a randomized, double-blind studyMehdi Hamedi, Mohammadreza Mohammdi, Ali Ghaleiha, et al.
Pageof 7